FDA defends lab test rule, as critics fear industry upheaval
BioPharma
Source: biopharmadive.com
📰 Clinical Laboratory Evaluation Program News
Page 2 - Clinical Laboratory Evaluation Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Laboratory Evaluation Program. Real-time updates on events, politics, business and more.
FDA Brings Lab Tests Under Its Oversight
Agency will treat lab-developed tests the same as other in vitro diagnostics
Source: medpagetoday.com
FDA Takes Action Aimed at Helping to Ensure the Safety and Effectiveness of Laboratory Developed Tests
Today, the U.S. Food and Drug Administration took action aimed at helping to ensure the safety and effectiveness of laboratory developed tests.
United States New York Jeff Shuren Robertm Califf Us Department Of Health York State Clinical Laboratory Evaluation Program
Source: fda.gov
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
/PRNewswire/ -- PreciseDx®, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven disease...
Los Angeles United States Hannah Davis Nicholas Stanzione Michaelj Donovan Clinical Laboratory Improvement Amendments
Source: prnewswire.com
FDA's Proposed Rule For Oversight Of Laboratory Developed Tests: Part II: FDA's Proposed Phaseout Policy – Key Considerations & Open Questions - Healthcare
After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs.
York State Department Of Health Clinical Laboratory Evaluation Program Veterans Health Administration Public Health Surveillance Academic Medical Centers Amcs Clinical Laboratory Improvement Amendments
Source: mondaq.com
Foundation Medicine and Natera Announce Broad Clinical Launch and Medicare Coverage of FoundationOneTracker
CAMBRIDGE - Foundation Medicine, Inc., and Natera, Inc., today announced the broad clinical launch of FoundationOneTracker, a personalized tissue-informed circulating tumor DNA test to monitor...
Source: marketscreener.com
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Applied DNA Sciences First Quarter Fiscal 2023 Financial Results Conference Call. All participants will be in a listen-only mode.
Source: insidermonkey.com
New York approves AI-driven breast cancer diagnostic
The state's health department has approved the PreciseDx Breast Test lab test which uses artificial intelligence to improve cancer grading and risk categorization
Source: healthcareitnews.com
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Clinical Utility and Benefit of clonoSEQ MRD Testing in Blood Cancer Patients at 2022 ASH Annual Meeting
05.12.2022 - SEATTLE, Dec. 05, 2022 (GLOBE NEWSWIRE) - Adaptive Biotechnologies Corporation (Nasdaq: ADPT), together with its collaborators, will present data from more than 30 abstracts showcasing the benefit of Adaptive’s next-generation sequencing ...
New York United States Ciltacabtagene Autoleucel Mary Pat Lancelotta Daratumumab Krd Dara Lenalidomide Vi
Source: wallstreet-online.de
Adaptive Announces Partnership with Epic to Increase Access to Minimal Residual Disease (MRD) Monitoring in Blood Cancers
Adaptive Announces Partnership with Epic to Increase Access to Minimal Residual Disease (MRD) Monitoring in Blood Cancers - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com